CM-272, CAS [[1846570-31-7]]
Artikelnummer:
MCE-HY-101925
| Artikelname: |
CM-272, CAS [[1846570-31-7]] |
| Artikelnummer: |
MCE-HY-101925 |
| Hersteller Artikelnummer: |
HY-101925 |
| Alternativnummer: |
MCE-HY-101925-10MMX1ML,MCE-HY-101925-100MG,MCE-HY-101925-50MG,MCE-HY-101925-25MG,MCE-HY-101925-10MG,MCE-HY-101925-5MG |
| Hersteller: |
MedchemExpress |
| Kategorie: |
Biochemikalien |
| CM-272 is a first-in-class, potent, selective, substrate-competitive and reversible dual G9a/DNA methyltransferases (DNMTs) inhibitor with antitumor activities. CM-272 inhibits G9a, DNMT1, DNMT3A, DNMT3B and GLP with IC50s of 8 nM, 382 nM, 85 nM, 1200 nM and 2 nM, respectively. CM-272 inhibits cell proliferation and promotes apoptosis, inducing IFN-stimulated genes and immunogenic cell death[1]. |
| Molekulargewicht: |
478.63 |
| Reinheit: |
98.70 |
| CAS Nummer: |
[1846570-31-7] |
| Formel: |
C28H38N4O3 |
| Target-Kategorie: |
Apoptosis,DNA Methyltransferase,Histone Methyltransferase |
| Anwendungsbeschreibung: |
MCE Product type: Reference compound |
